
49.46 Delayed Data As of May 20 | ![]() Today’s Change | 48.76 Today|||52-Week Range 54.99 | -5.53% Year-to-Date |
The investment seeks to provide long-term capital appreciation. The adviser seeks to meet its objective by investing primarily in equities, including common stock, preferred stock and bonds which are convertible to common stock, that the adviser identifies to be attractively valued given their growth potential over a long-term time horizon. The securities held by the fund will predominantly be of companies with market capitalizations similar to those within the universe of the Russell 1000 Value Index (which includes both large cap and mid cap companies).
1 month | -8.50% | 3 years | -- | |
3 months | -5.97% | 5 years | -- | |
1 year | -- | Since inception | +1.16% |
Previous close | $49.76 |
Open day’s range | 48.76 – 49.46 |
Net asset value (NAV) | 49.72 (05/19/2022) |
Daily volume | 6,166 |
Average volume (3 months) | 6,333 |
JAVA | Category | |
---|---|---|
Performance 5-yr return | -- | +10.82% |
Expense Gross exp ratio | 0.44% | 0.92% |
Risk 5 year sharpe ratio | -- | 0.56 |
Net assets | $39.5M | $3.2B |
Average market cap | $82.2B | $105.9B |
Average P/E | 17.8 | 14.8 |
Dividend / Share | -- | 0.18% |
No competitors data available. |
Business service | -- |
Consumer goods | -- |
Consumer service | -- |
Energy | -- |
Financial service | -- |
BMY Bristol-Myers Squibb | 3.02% |
WFC Wells Fargo | 2.86% |
-- | 2.64% |
BAC Bank of America | 2.62% |
RTX Raytheon Technologies Corp | 2.22% |
CVX Chevron | 2.18% |
ZBH Zimmer Biomet Holdings Inc | 1.77% |
CI Cigna Corp | 1.63% |
VRTX Vertex Pharmaceuticals Inc | 1.60% |
HES Hess | 1.59% |